ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: G. Pellegrino (Milano, Italy), F. Sciurba (Pittsburgh, United States of America)

Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study J. Corren (Los Angeles, United States of America)
Late Breaking Abstract - The association between dynamic lung function and peak oxygen uptake in a healthy general population. The HUNT Study. Ø. Rasch-Halvorsen (TRONDHEIM, Norway)
Late Breaking Abstract - Global RSV-associated mortality in young children: a case series. N. Scheltema (Utrecht, Netherlands)
Late Breaking Abstract - EvA consortium: bronchial brush bacterial load is associated with airway remodelling in mild-to-moderate COPD M. Yavari Ramsheh (Leicester, United Kingdom)
Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS) A. Woodcock (Manchester, United Kingdom)
Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD F. Sciurba (Pittsburgh, United States of America)